Ophthalmology

Top Story

Alimera allowed to reduce size of Iluvien study in UK

July 21, 2017

The United Kingdom’s Medicines and Healthcare Products Regulatory Agency has given final approval to reduce the size of Alimera Sciences’ post-marketing study of Iluvien, according to a company press release.

The study, originally intended to follow 800 patients over 5 years, has shown consistent positive safety data, leading the company to seek a smaller sample size, the release said. There are currently 550 patients enrolled.

Voretigene neparvovec receives rare pediatric disease designation from FDA

July 21, 2017
The FDA offices of Orphan Products Development and Pediatric Therapeutics have designated voretigene neparvovec as a drug for a rare pediatric disease, according to a…

Akorn shareholders approve Fresenius Kabi merger

July 21, 2017
Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release. Fresenius Kabi announced in April that it
In the Journals

Amniotic membrane transplantation adds to benefits of antibiotics in bacterial keratitis

July 20, 2017
The combination of amniotic membrane transplantation and antibiotic therapy leads to significantly better results than antibiotic therapy alone in eyes with bacterial…

NIH awards $1.9 million grant to study bacterial endophthalmitis

July 20, 2017
The National Eye Institute of the National Institutes of Health has awarded a $1.9 million grant to a Wayne State University School of Medicine researcher, according to…
More News Headlines »
Clinical Science

Retinal Ganglion Cell Loss in Children With Type 1 Diabetes Mellitus Without Diabetic Retinopathy

Ophthalmic Surgery, Lasers and Imaging Retina, June 2017, Volume 48 Issue 6
Early diabetic retinal changes in children with type 1 diabetes mellitus (T1DM) without diabetic retinopathy (DR) were…
More »
CME

Treating Advanced Dry Age-related Macular Degeneration and Geographic Atrophy: Here and Now

This activity is supported by an educational grant from Allergan, Inc.

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the…
More »
Resource Centers
Video
Meeting News

VIDEO: Mazzo discusses cooperation of large, small companies in ophthalmology

June 23, 2017
More »
Advertisement
Advertisement